Amphion Innovations plc

Amphion Innovations plc

Amphion Innovations plc was founded in 1984 and is based in Douglas, United Kingdom with additional offices in London, United Kingdom and New York, New York. Amphion Innovations plc is a principal investment firm specializing in both public and private early stage investments and spun out of universities and corporations. It does not invest in “speculative” technologies requiring long development timeframes or excessive capital investment. It invests in the medical, life sciences, and technology sectors with defensible core intellectual property, know-how and growth potential in very large markets of at least $1 billion in size together with corporations, governments, universities, and entrepreneurs. The firm typically invests in companies with broad-based, proprietary, platform technologies in the areas of pharmacogenomics, proteomics, nutriceuticals or wellness, diagnostics, medical products and related fields, leveraging advances in and the convergence of materials science and life science IT, particularly software technologies. It targets investments in companies based in both the United States and United Kingdom. The firm makes investments in a company that requires capital of up to $5 million as new capital in the first one to two years, with later, additional capital requirements of between $15 million and $25 million and is at least $1 billion in size. It acts as a lead investor and seeks to acquire a sizable ownership stake and measure of influence or control in its portfolio companies.

Contact Details

Office Address

Amphion Innovations plc
10 Greycoat Place
Westminster London, UK SW1P1SB
Phone: +44-20-7016-8821
Fax: +44-20-7016-9100

Executives

Chairman

Richard M. Mansell-Jones

CEO and Director

Richard C. E. Morgan

President, CFO, and Director

Robert J. Bertoldi

Business Reviews for Amphion Innovations plc

Related Companies